Vor Biopharma Inc. (VOR) delivered a return of 220.23% over the past year. Since VOR does not currently pay dividends, the total return equals the price-only return.

A $10,000 investment in Vor Biopharma Inc. one year ago would be worth $32,023 today, representing a gain of $22,023.

Vor Biopharma Inc. (VOR) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For VOR, the total return equals the price-only return.

Yes, Vor Biopharma Inc. (VOR) outperformed the S&P 500 by 197.55 percentage points over the past year. VOR delivered a total return of 220.23%, compared to the S&P 500's 22.68%. This 197.55pp alpha means investors in VOR earned more than a passive S&P 500 index fund.

Vor Biopharma Inc. (VOR) experienced a maximum drawdown of -87.15% over the past year, declining from its peak on 2025-07-07 to its trough on 2025-11-20. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Here are Vor Biopharma Inc. (VOR)'s long-term returns with dividends reinvested. Over 10 years, the total return is -98.1% (-32.8% CAGR) — $10,000 would have grown to $188. Over 20 years: -98.1% total return (-18.0% CAGR) — $10,000 → $188. Over 30 years: -98.1% total return (-12.4% CAGR) — $10,000 → $188. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Vor Biopharma Inc.'s best calendar year was 2025 with a total return of -41.6%. Its worst year was 2021 with a total return of -69.0%. This range shows the volatility investors should expect — the difference between the best and worst year is 27.4 percentage points.